Literature DB >> 3943025

Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.

M Gion, R Mione, R Dittadi, S Fasan, A Pallini, G Bruscagnin.   

Abstract

In 225 primary breast carcinomas the concentrations of carcinoembryonic antigen (CEA), ferritin, and tissue polypeptide antigen (TPA) were determined by radioimmunometric assays both in serum and in cytosol. The relationship of the three markers with the receptor content of the tumor was evaluated. No relationships were found between the serum level of each marker and the receptor status. In the cytosol, ferritin was higher in receptor-negative than in receptor-positive cases, whereas CEA and TPA showed significantly higher values in receptor-positive than in receptor-negative patients. Moreover, a direct relationship was found between estrogen receptor and both CEA and TPA and between progesterone receptor and TPA. Even if the significance of these findings is still unclear, from our data it can be concluded that there exists a noncasual relationship between the receptor status and the cytosol content of CEA and, particularly, TPA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943025     DOI: 10.1002/1097-0142(19860301)57:5<917::aid-cncr2820570506>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Tissue ferritin concentration and prognosis in carcinoma of the breast.

Authors:  R E Weinstein; B H Bond; B K Silberberg; C B Vaughn; P Subbaiah; D R Pieper
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

2.  Value of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis.

Authors:  E Vizcarra; A Lluch; R Cibrián; F Jarque; V Alberola; V Belloch; J García-Conde
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  The significance of determining CA 15-3 in the cytosol of breast cancer.

Authors:  K Kosian; C Bieglmayer; W Neunteufel; C Dadak
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.

Authors:  M Gion; R Mione; C Gatti; R Dittadi; A Leon; C Castiglioni; O Nascimben; G Bruscagnin
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

5.  Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up.

Authors:  F A Mauri; O Caffo; S Veronese; P Verderio; P Boracchi; M Bonzanini; N Rossi; G Perrone; P Dalla Palma; M Barbareschi
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

6.  PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.

Authors:  M Gion; R Mione; G L Pappagallo; C Gatti; O Nascimben; M Bari; A E Leon; O Vinante; G Bruscagnin
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.